Procept Biorobotics Debt 2024

Procept Biorobotics Aktienanalyse

What does Procept Biorobotics do?

PROCEPT BioRobotics Corp (PROCEPT) is a California-based medical technology company specializing in the development of robotic technologies for urological surgery. History: PROCEPT was founded in 2013 by Dr. Chin and his group at Johns Hopkins University School of Medicine. They developed a novel technology that had the potential to revolutionize the treatment of prostate cancer. PROCEPT used a robust Intuitive Surgical platform and developed a novel tissue classification technology that allows surgeons to operate with accuracy and safety. The first system, called AquaBeam®, was approved by the US Food and Drug Administration (FDA) in 2018 and has since been in use in Europe and the US. Business: PROCEPT aims to improve urological surgery through the use of robotic technologies, thereby increasing patient safety and care. The company focuses on the development and commercialization of robotic systems for the treatment of prostate cancer and other urological diseases. Products: PROCEPT has developed Aquablation®, a robotic system for the treatment of prostate cancer. It is a minimally invasive technology that uses high-precision waterjet cutting (accuracy reduced to millimeters) to remove cancerous tissue quickly, effectively, and accurately. The technology can also be used in surgical procedures on the bladder, urethra, and other urological organs. Divisions: PROCEPT has a broad portfolio of services and products in the field of urological surgery. The AquaBeam® technology is the first system developed to treat malignant prostate tumors using robotic technologies. The technology is used in hospitals, clinics, and medical facilities worldwide. In addition, PROCEPT offers training and support for surgeons and medical personnel. Conclusion: PROCEPT BioRobotics Corp is an emerging medical technology company specializing in robotics-based urological surgery. The AquaBeam® technology is an innovative, robotic technology for the treatment of prostate cancer. The company is on its way to revolutionizing urological surgery and making a significant contribution to improving healthcare. Procept Biorobotics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Procept Biorobotics's Debt Structure

Procept Biorobotics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Procept Biorobotics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Procept Biorobotics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Procept Biorobotics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Procept Biorobotics stock

What is the debt of Procept Biorobotics this year?

Procept Biorobotics has a debt level of -199.27 USD this year.

What was the debt of Procept Biorobotics compared to the previous year?

The debt of Procept Biorobotics has increased by 16.74% compared to the previous year increased.

What are the consequences of high debt for investors in Procept Biorobotics?

High debt can pose a risk for investors of Procept Biorobotics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Procept Biorobotics?

Low debt means that Procept Biorobotics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Procept Biorobotics affect the company?

An increase in debt of Procept Biorobotics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Procept Biorobotics affect the company?

A reduction in debt of Procept Biorobotics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Procept Biorobotics?

Some factors that can influence the debt of Procept Biorobotics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Procept Biorobotics so important for investors?

The debts of Procept Biorobotics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Procept Biorobotics take to change the debt?

To change the debt, Procept Biorobotics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Procept Biorobotics pay?

Over the past 12 months, Procept Biorobotics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Procept Biorobotics is expected to pay a dividend of 0 USD.

What is the dividend yield of Procept Biorobotics?

The current dividend yield of Procept Biorobotics is .

When does Procept Biorobotics pay dividends?

Procept Biorobotics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Procept Biorobotics?

Procept Biorobotics paid dividends every year for the past 0 years.

What is the dividend of Procept Biorobotics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Procept Biorobotics located?

Procept Biorobotics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Procept Biorobotics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Procept Biorobotics from 12/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/17/2024.

When did Procept Biorobotics pay the last dividend?

The last dividend was paid out on 12/17/2024.

What was the dividend of Procept Biorobotics in the year 2023?

In the year 2023, Procept Biorobotics distributed 0 USD as dividends.

In which currency does Procept Biorobotics pay out the dividend?

The dividends of Procept Biorobotics are distributed in USD.